Страница результатов 10 - Сектор: Здравоохранение Отрасль: Биотехнологии Котировки акций и цены - фондовый рынок
Список всех акций публичных компаний с указанием цен, рыночной капитализации, PE и EPS
Все страны
- {{country.name}}
- Все страны
- Соединенные Штаты (647)
- Австралия (45)
- Австрия (11)
- Бельгия (7)
- Бразилия (13)
- Канада (48)
- Китай (89)
- Дания (6)
- Финляндия (3)
- Франция (26)
- Германия (444)
- Гонконг (45)
- Индия (21)
- Израиль (13)
- Италия (3)
- Япония (37)
- Мексика (26)
- Нидерланды (3)
- Новая Зеландия (1)
- Норвегия (10)
- Польша (8)
- Россия (1)
- Южная Корея (79)
- Испания (3)
- Швеция (58)
- Швейцария (10)
- Тайвань (60)
- Таиланд (2)
- Турция (1)
- Великобритания (25)
Все биржи
- {{item.name}}
- Все биржи
- Amsterdam (3)
- Aquis AQSE (1)
- ASX (45)
- Brussels (7)
- BSE (13)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (389)
- Hamburg (1)
- Helsinki (3)
- HKSE (45)
- IOB (24)
- Istanbul (1)
- KOSDAQ (69)
- KSE (10)
- MCE (3)
- MCX (1)
- Mexico (26)
- Milan (3)
- Munich (17)
- NSE (8)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (40)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (29)
- OTC Markets OTCQX (5)
- Paris (26)
- São Paulo (13)
- Shanghai (46)
- Shenzhen (43)
- Stockholm (58)
- Stuttgart (21)
- Swiss (10)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (153)
- Tech Market Middle (83)
- Tech Market Small (210)
- Tel Aviv (13)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (15)
Здравоохранение (1745)
- {{item.name}}
- Все секторы
- Здравоохранение (1745)
Биотехнологии (1745)
- {{item.name}}
- Все отрасли
- Биотехнологии (1745)
- Производители лекарств-Общие (1)
- Производители лекарств-Специализированные и дженерики (77)
- Планы здравоохранения (45)
- Медицинские учреждения (434)
- Розничные продавцы фармацевтической продукции (103)
- Информационные службы здравоохранения (256)
- Медицинские приборы (739)
- Медицинские инструменты и принадлежности (430)
- Диагностика и исследования (339)
- Медицинская дистрибуция (148)
| Название Название | Цена Цена |
24h% 7d chart 24h% & 7d |
Рын. Кап. Капитализация | Объём Объём | 24ч мин | 24ч макс | Капитализация | Цена/доход | Прибыль на акцию | Прогноз |
|---|
| Название Название | Цена Цена |
24h% 7d chart 24h% & 7d |
Рын. Кап. Капитализация | Объём Объём | 24ч мин | 24ч макс | Капитализация | Цена/доход | Прибыль на акцию | Прогноз | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
UCB SA
UCB.VI
AT
|
€254.30 293.55 USD |
+0.91
|
€48.41B 55.88B USD | €0.00 0 USD | €251.10 289.85 USD | €254.80 294.12 USD | €48.41B 55.88B USD | 31.62 | €8.04 9.28 USD | ||
UCB SA
UNC.F
DE
|
€251.50 290.32 USD |
+2.44
|
€47.88B 55.26B USD | €3.00 3.46 USD | €251.50 290.32 USD | €251.50 290.32 USD | €47.88B 55.26B USD | 31.32 | €8.03 9.27 USD | ||
|
argenx SE
1AEA.MU
DE
|
€765.00 883.07 USD |
0
|
€47.57B 54.92B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €47.57B 54.92B USD | 38.61 | €19.81 22.87 USD | ||
UCB SA
UCBJF
US
|
$288.40 — |
-0.83
|
$54.90B — | $165.00 — | $290.00 — | $290.00 — | $54.90B — | 31.45 | $9.17 — | ||
|
argenx SE
1AE.F
DE
|
€761.00 878.45 USD |
-6.63
|
€47.32B 54.63B USD | €165.00 190.47 USD | €758.00 874.99 USD | €771.60 890.68 USD | €47.32B 54.63B USD | 38.45 | €19.79 22.84 USD | ||
|
argenx SE
ARGX.VI
AT
|
€747.20 862.52 USD |
-8.07
|
€46.97B 54.22B USD | €0.00 0 USD | €747.20 862.52 USD | €773.60 892.99 USD | €46.97B 54.22B USD | 37.87 | €19.73 22.78 USD | ||
argenx SE
1AEA.F
DE
|
€740.00 854.21 USD |
-3.9
|
€46.02B 53.12B USD | €3.00 3.46 USD | €740.00 854.21 USD | €740.00 854.21 USD | €46.02B 53.12B USD | 37.44 | €19.76 22.81 USD | ||
Samsung Biologics Co.,Ltd.
207940.KS
KR
|
₩1,401,000 1057.53 USD |
+1.15
|
₩65T 48.95B USD | ₩51K 38.86 USD | ₩1,361,000 1027.33 USD | ₩1,428,000 1077.91 USD | ₩65T 48.95B USD | 0 | ₩0 0 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.DE
DE
|
€259.00 298.97 USD |
+2.57
|
€34.58B 39.92B USD | €17.00 19.62 USD | €258.90 298.86 USD | €259.00 298.97 USD | €34.58B 39.92B USD | 74.00 | €3.50 4.04 USD | ||
Alnylam Pharmaceuticals, Inc.
DUL.F
DE
|
€258.80 298.74 USD |
+2.13
|
€34.55B 39.89B USD | €10.00 11.54 USD | €251.40 290.2 USD | €264.70 305.55 USD | €34.55B 39.89B USD | 74.15 | €3.49 4.03 USD | ||
Alnylam Pharmaceuticals, Inc.
A1LN34.SA
BR
|
R$71.82 14.56 USD |
0
|
R$191.78B 38.87B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$191.78B 38.87B USD | 69.72 | R$1.03 0.21 USD | ||
CSL Limited
CSJ.F
DE
|
€69.16 79.83 USD |
+2.34
|
€33.12B 38.23B USD | €260.00 300.13 USD | €69.16 79.83 USD | €69.16 79.83 USD | €33.12B 38.23B USD | 12.76 | €5.42 6.26 USD | ||
CSL
CMXHF
US
|
$76.85 — |
+1.05
|
$36.80B — | $100.00 — | $66.00 — | $66.00 — | $36.80B — | 12.45 | $6.17 — | ||
|
Revolution Medicines, Inc.
42Z.F
DE
|
€147.65 170.44 USD |
-0.87
|
€31.39B 36.23B USD | €100.00 115.43 USD | €147.65 170.44 USD | €151.05 174.36 USD | €31.39B 36.23B USD | 0 | -€6.25 -7.2 USD | ||
CSL Limited
CSJA.F
DE
|
€16.00 18.47 USD |
-0.62
|
€30.65B 35.38B USD | €100.00 115.43 USD | €16.00 18.47 USD | €16.00 18.47 USD | €30.65B 35.38B USD | 11.76 | €1.36 1.57 USD | ||
Royalty Pharma plc
RPD.MU
DE
|
€48.21 55.64 USD |
+4.08
|
€27.76B 32.04B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €27.76B 32.04B USD | 28.86 | €1.67 1.93 USD | ||
Royalty Pharma plc
RPD.F
DE
|
€48.16 55.59 USD |
+4.31
|
€27.73B 32.01B USD | €140.00 161.61 USD | €48.16 55.59 USD | €48.16 55.59 USD | €27.73B 32.01B USD | 29.01 | €1.66 1.92 USD | ||
Celltrion, Inc.
068270.KS
KR
|
₩174,300 131.57 USD |
+0.93
|
₩40T 30.17B USD | ₩472K 356.47 USD | ₩170,600 128.78 USD | ₩180,300 136.1 USD | ₩40T 30.17B USD | 0 | ₩0 0 USD | ||
|
BeOne Medicines AG
49BA.F
DE
|
€242.00 279.35 USD |
+4.31
|
€25.11B 28.98B USD | €20.00 23.09 USD | €242.00 279.35 USD | €242.00 279.35 USD | €25.11B 28.98B USD | 62.05 | €3.90 4.5 USD | ||
Royalty Pharma plc
RPRXN.MX
MX
|
MX$775.06 45.89 USD |
0
|
MX$446.30B 26.43B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$446.30B 26.43B USD | 23.69 | MX$32.71 1.94 USD | ||
|
Moderna, Inc.
MRNA.MX
MX
|
MX$1,075.00 63.65 USD |
-1.58
|
MX$426.55B 25.26B USD | MX$1.17K 69.04 USD | MX$1,074.00 63.59 USD | MX$1,083.10 64.13 USD | MX$426.55B 25.26B USD | 0 | -MX$141.40 -8.3 USD | ||
|
Moderna, Inc.
MRNA.VI
AT
|
€54.91 63.38 USD |
+0.77
|
€21.79B 25.15B USD | €7.11K 8.21K USD | €53.45 61.7 USD | €55.26 63.79 USD | €21.79B 25.15B USD | 0 | -€7.12 -8.2 USD | ||
BioNTech SE
0A3M.IL
GB
|
$90.25 — |
-0.55
|
$24.82B — | $0.00 — | $0.00 — | $0.00 — | $24.82B — | 5.01 | $18.00 — | ||
Moderna, Inc.
0QF.MU
DE
|
€54.00 62.33 USD |
+5.32
|
€21.43B 24.73B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €21.43B 24.73B USD | 0 | -€7.16 -8.2 USD | ||
Moderna, Inc.
0QF.F
DE
|
€53.74 62.03 USD |
-1.36
|
€21.32B 24.61B USD | €626.00 722.61 USD | €53.29 61.51 USD | €54.45 62.85 USD | €21.32B 24.61B USD | 0 | -€7.15 -8.2 USD | ||
|
BioNTech SE
B1NT34.SA
BR
|
R$29.49 5.98 USD |
+0.1
|
R$120.52B 24.43B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$120.52B 24.43B USD | 0 | -R$1.87 -0.3 USD | ||
|
BioNTech SE
BNTXN.MX
MX
|
MX$1,590.00 94.15 USD |
+1.92
|
MX$402.09B 23.81B USD | MX$448.00 26.53 USD | MX$1,590.00 94.15 USD | MX$1,590.00 94.15 USD | MX$402.09B 23.81B USD | 0 | -MX$100.62 -5.9 USD | ||
|
Roivant Sciences Ltd.
87S.F
DE
|
€28.07 32.4 USD |
+2.11
|
€20.19B 23.31B USD | €39.00 45.02 USD | €27.96 32.28 USD | €28.07 32.4 USD | €20.19B 23.31B USD | 0 | -€0.47 -0.5 USD | ||
|
BioNTech SE
BNTX.VI
AT
|
€79.65 91.94 USD |
-0.31
|
€20.14B 23.25B USD | €1.00 1.15 USD | €79.50 91.77 USD | €79.70 92 USD | €20.14B 23.25B USD | 0 | -€5.07 -5.8 USD | ||
BioNTech SE
22UA.F
DE
|
€79.20 91.42 USD |
-1.37
|
€20.03B 23.12B USD | €137.00 158.14 USD | €78.85 91.02 USD | €79.55 91.83 USD | €20.03B 23.12B USD | 0 | -€5.07 -5.8 USD | ||
|
Insmed Incorporated
IM8N.SG
DE
|
€90.79 104.8 USD |
+1.44
|
€19.68B 22.72B USD | €80.00 92.35 USD | €89.01 102.75 USD | €93.11 107.48 USD | €19.68B 22.72B USD | 0 | -€5.04 -5.8 USD | ||
|
Insmed Incorporated
IM8N.F
DE
|
€88.96 102.69 USD |
-0.41
|
€19.28B 22.26B USD | €123.00 141.98 USD | €88.96 102.69 USD | €88.96 102.69 USD | €19.28B 22.26B USD | 0 | -€5.06 -5.8 USD | ||
|
Incyte Corporation
ICY.F
DE
|
€91.06 105.11 USD |
+0.15
|
€18.19B 21B USD | €22.00 25.4 USD | €91.06 105.11 USD | €91.06 105.11 USD | €18.19B 21B USD | 14.63 | €6.22 7.18 USD | ||
|
Incyte Corporation
I1NC34.SA
BR
|
R$253.50 51.38 USD |
0
|
R$101.29B 20.53B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$101.29B 20.53B USD | 13.89 | R$18.25 3.7 USD | ||
|
Genmab A/S
0MGB.IL
GB
|
DKK 1,703.00 249.7 USD |
-0.21
|
DKK 136.38B 20B USD | DKK 671.00 98.38 USD | DKK 0.00 0 USD | DKK 0.00 0 USD | DKK 136.38B 20B USD | 24.06 | DKK 70.77 10.38 USD | ||
|
Incyte Corporation
INCY.MX
MX
|
MX$1,676.03 99.24 USD |
0
|
MX$334.84B 19.83B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$334.84B 19.83B USD | 13.62 | MX$123.02 7.28 USD | ||
Innovent Biologics, Inc.
6IB.F
DE
|
€8.63 9.97 USD |
+2.54
|
€14.98B 17.29B USD | €100.00 115.43 USD | €8.59 9.92 USD | €8.63 9.97 USD | €14.98B 17.29B USD | 143.88 | €0.06 0.07 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW2.F
DE
|
€3.62 4.18 USD |
+7.26
|
€14.87B 17.17B USD | €2.50K 2.89K USD | €3.62 4.18 USD | €3.62 4.18 USD | €14.87B 17.17B USD | 24.13 | €0.15 0.17 USD | ||
|
WuXi Biologics (Cayman) Inc.
1FW1.F
DE
|
€7.10 8.2 USD |
+6.77
|
€14.59B 16.84B USD | €100.00 115.43 USD | €7.10 8.2 USD | €7.10 8.2 USD | €14.59B 16.84B USD | 23.66 | €0.30 0.35 USD | ||
WuXi Biologics (Cayman)
WXIBF
US
|
$4.00 — |
0
|
$16.43B — | $250.00 — | $4.40 — | $4.40 — | $16.43B — | 23.52 | $0.17 — | ||
Genmab A/S
GE91.F
DE
|
€22.60 26.09 USD |
+3.67
|
€13.87B 16.02B USD | €600.00 692.6 USD | €22.60 26.09 USD | €22.60 26.09 USD | €13.87B 16.02B USD | 19.65 | €1.15 1.33 USD | ||
|
Genmab A/S
GNMSF
US
|
$257.44 — |
0
|
$15.81B — | $10.00 — | $250.00 — | $250.00 — | $15.81B — | 19.57 | $13.15 — | ||
|
GENMAB AS N
GE9.DE
DE
|
€220.00 253.95 USD |
+0.92
|
€13.51B 15.59B USD | €222.00 256.26 USD | €216.50 249.91 USD | €216.50 249.91 USD | €13.51B 15.59B USD | 19.03 | €11.56 13.34 USD | ||
ALTEOGEN Inc.
196170.KQ
KR
|
₩384,000 289.86 USD |
+3.36
|
₩21T 15.51B USD | ₩742K 560.16 USD | ₩365,000 275.52 USD | ₩397,500 300.05 USD | ₩21T 15.51B USD | 0 | ₩0 0 USD | ||
Jazz Pharmaceuticals plc
J7Z.F
DE
|
€202.20 233.41 USD |
+0.1
|
€12.70B 14.66B USD | €2.02K 2.33K USD | €201.40 232.48 USD | €203.60 235.02 USD | €12.70B 14.66B USD | 2022.00 | €0.10 0.12 USD | ||
Ascendis Pharma A/S
A71.F
DE
|
€206.00 237.79 USD |
0
|
€12.65B 14.6B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.65B 14.6B USD | 0 | €0.00 0 USD | ||
Verona Pharma plc
I9SA.F
DE
|
€90.20 104.12 USD |
0
|
€12.13B 14.01B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €12.13B 14.01B USD | 0 | €0.00 0 USD | ||
Sino Biopharmaceutical Limited
SBMFF
US
|
$0.78 — |
-6.28
|
$13.87B — | $2.00K — | $0.78 — | $0.78 — | $13.87B — | 38.89 | $0.02 — | ||
|
BridgeBio Pharma, Inc.
2CL.F
DE
|
€60.28 69.58 USD |
+1.6
|
€11.81B 13.63B USD | €300.00 346.3 USD | €60.28 69.58 USD | €60.28 69.58 USD | €11.81B 13.63B USD | 0 | -€3.29 -3.7 USD | ||
Exelixis, Inc.
EX9.F
DE
|
€44.78 51.69 USD |
+1.42
|
€11.26B 12.99B USD | €200.00 230.87 USD | €44.78 51.69 USD | €44.78 51.69 USD | €11.26B 12.99B USD | 16.96 | €2.64 3.05 USD | ||
|
Axsome Therapeutics, Inc.
19X.F
DE
|
€210.80 243.33 USD |
-1.72
|
€10.85B 12.52B USD | €50.00 57.72 USD | €210.80 243.33 USD | €210.80 243.33 USD | €10.85B 12.52B USD | 0 | -€3.27 -3.7 USD | ||
|
Madrigal Pharmaceuticals, Inc.
YDO1.F
DE
|
€446.70 515.64 USD |
-0.42
|
€10.30B 11.89B USD | €5.00 5.77 USD | €446.70 515.64 USD | €456.60 527.07 USD | €10.30B 11.89B USD | 0 | -€11.83 -13.6 USD | ||
Arrowhead Pharmaceuticals, Inc.
HDP1.F
DE
|
€69.72 80.48 USD |
-1.05
|
€9.82B 11.34B USD | €200.00 230.87 USD | €69.70 80.46 USD | €72.26 83.41 USD | €9.82B 11.34B USD | 0 | -€1.99 -2.2 USD | ||
|
Sino Biopharmaceutical
SBHMY
US
|
$12.68 — |
+5.1
|
$11.31B — | $128.00 — | $12.68 — | $12.68 — | $11.31B — | 33.36 | $0.38 — | ||
|
BioMarin Pharmaceutical Inc.
BMRN.VI
AT
|
€50.56 58.36 USD |
+2.47
|
€9.77B 11.28B USD | €0.00 0 USD | €49.89 57.59 USD | €50.56 58.36 USD | €9.77B 11.28B USD | 41.44 | €1.22 1.41 USD | ||
Ionis Pharmaceuticals, Inc.
IONS.MX
MX
|
MX$1,150.00 68.09 USD |
0
|
MX$190.05B 11.25B USD | MX$0.00 0 USD | MX$1,150.00 68.09 USD | MX$1,150.00 68.09 USD | MX$190.05B 11.25B USD | 0 | -MX$28.98 -1.7 USD | ||
|
Financière de Tubize SA
FTD.SG
DE
|
€216.80 250.26 USD |
+0.84
|
€9.65B 11.14B USD | €1.00 1.15 USD | €214.60 247.72 USD | €218.60 252.34 USD | €9.65B 11.14B USD | 103.73 | €2.09 2.41 USD | ||
|
BioMarin Pharmaceutical Inc.
BM8.F
DE
|
€49.79 57.47 USD |
+3.9
|
€9.62B 11.11B USD | €100.00 115.43 USD | €49.79 57.47 USD | €49.79 57.47 USD | €9.62B 11.11B USD | 40.81 | €1.22 1.41 USD | ||
|
BioMarin Pharmaceutical Inc.
B1MR34.SA
BR
|
R$140.85 28.55 USD |
0
|
R$54.45B 11.04B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$54.45B 11.04B USD | 39.34 | R$3.58 0.73 USD | ||
|
Financière de Tubize SA
FTD.F
DE
|
€214.00 247.03 USD |
+1.04
|
€9.53B 11B USD | €100.00 115.43 USD | €214.00 247.03 USD | €214.00 247.03 USD | €9.53B 11B USD | 101.90 | €2.10 2.42 USD | ||
|
BioMarin Pharmaceutical Inc.
BMRN.MX
MX
|
MX$959.00 56.78 USD |
0
|
MX$185.36B 10.98B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$185.36B 10.98B USD | 39.67 | MX$24.17 1.43 USD | ||
|
Cytokinetics, Incorporated
KK3A.F
DE
|
€69.34 80.04 USD |
-0.52
|
€9.41B 10.87B USD | €12.00 13.85 USD | €69.34 80.04 USD | €69.34 80.04 USD | €9.41B 10.87B USD | 0 | -€5.99 -6.9 USD | ||
|
Akeso, Inc.
4RY.F
DE
|
€9.72 11.22 USD |
+2.25
|
€8.95B 10.34B USD | €200.00 230.87 USD | €9.72 11.22 USD | €9.78 11.28 USD | €8.95B 10.34B USD | 0 | -€0.16 -0.1 USD | ||
|
Krystal Biotech, Inc.
4KB.SG
DE
|
€303.00 349.76 USD |
+1.68
|
€8.93B 10.31B USD | €0.00 0 USD | €303.00 349.76 USD | €303.00 349.76 USD | €8.93B 10.31B USD | 46.11 | €6.57 7.58 USD | ||
Sino Biopharmaceutical Limited
SMZ1.F
DE
|
€0.49 0.57 USD |
+0.24
|
€8.76B 10.11B USD | €2.17K 2.5K USD | €0.49 0.57 USD | €0.49 0.57 USD | €8.76B 10.11B USD | 24.56 | €0.02 0.02 USD | ||
Krystal Biotech, Inc.
4KB.F
DE
|
€296.80 342.61 USD |
-0.4
|
€8.75B 10.1B USD | €18.00 20.78 USD | €296.80 342.61 USD | €296.80 342.61 USD | €8.75B 10.1B USD | 45.24 | €6.56 7.57 USD | ||
|
Bio-Techne Corporation
TECH.MX
MX
|
MX$1,064.35 63.02 USD |
0
|
MX$169.12B 10.01B USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$169.12B 10.01B USD | 0 | MX$0.00 0 USD | ||
|
Bio-Techne Corporation
T1CH34.SA
BR
|
R$10.27 2.08 USD |
+7.09
|
R$48.24B 9.78B USD | R$0.00 0 USD | R$0.00 0 USD | R$0.00 0 USD | R$48.24B 9.78B USD | 85.58 | R$0.12 0.02 USD | ||
|
Jazz Pharmaceuticals plc
JAZZN.MX
MX
|
MX$2,500.00 148.03 USD |
0
|
MX$157.04B 9.3B USD | MX$0.00 0 USD | MX$2,500.00 148.03 USD | MX$2,500.00 148.03 USD | MX$157.04B 9.3B USD | 0 | -MX$106.00 -6.2 USD | ||
|
ALK-Abelló A/S
AKBLF
US
|
$40.65 — |
0
|
$9.01B — | $105.00 — | $31.35 — | $31.35 — | $9.01B — | 45.67 | $0.89 — | ||
Bio-Techne Corporation
TE1.F
DE
|
€49.20 56.79 USD |
+4.19
|
€7.70B 8.89B USD | €13.00 15.01 USD | €49.20 56.79 USD | €49.20 56.79 USD | €7.70B 8.89B USD | 79.35 | €0.62 0.72 USD | ||
|
ALK-Abelló A/S
4AJ0.F
DE
|
€34.06 39.32 USD |
+0.95
|
€7.55B 8.71B USD | €9.00 10.39 USD | €34.06 39.32 USD | €34.06 39.32 USD | €7.55B 8.71B USD | 43.66 | €0.78 0.9 USD | ||
|
Corcept Therapeutics Incorporated
HTD.F
DE
|
€69.44 80.16 USD |
-1.42
|
€7.45B 8.6B USD | €8.00 9.23 USD | €69.44 80.16 USD | €69.44 80.16 USD | €7.45B 8.6B USD | 231.46 | €0.30 0.35 USD | ||
|
Halozyme Therapeutics, Inc.
HALO.MX
MX
|
MX$1,199.59 71.03 USD |
0
|
MX$142.29B 8.43B USD | MX$200.00 11.84 USD | MX$0.00 0 USD | MX$0.00 0 USD | MX$142.29B 8.43B USD | 24.21 | MX$49.54 2.93 USD | ||
Halozyme Therapeutics, Inc.
RV7.F
DE
|
€61.02 70.44 USD |
+1.8
|
€7.24B 8.35B USD | €260.00 300.13 USD | €61.02 70.44 USD | €61.02 70.44 USD | €7.24B 8.35B USD | 24.40 | €2.50 2.89 USD | ||
|
TG Therapeutics, Inc.
NKB2.F
DE
|
€46.90 54.14 USD |
+1.96
|
€7.18B 8.29B USD | €400.00 461.73 USD | €46.90 54.14 USD | €46.90 54.14 USD | €7.18B 8.29B USD | 18.76 | €2.50 2.89 USD | ||
ImmunityBio, Inc.
26CA.F
DE
|
€6.83 7.88 USD |
+6.22
|
€7.15B 8.26B USD | €1.70K 1.96K USD | €6.37 7.35 USD | €6.90 7.96 USD | €7.15B 8.26B USD | 0 | -€0.75 -0.8 USD | ||
Biocon Limited
BIOCON.BO
IN
|
₹419.60 5.08 USD |
-0.5
|
₹679.55B 8.22B USD | ₹26.52K 320.79 USD | ₹416.70 5.04 USD | ₹425.40 5.15 USD | ₹679.55B 8.22B USD | 148.26 | ₹2.83 0.03 USD | ||
ABIVAX Société Anonyme
2X1.F
DE
|
€85.70 98.93 USD |
-4.03
|
€6.84B 7.89B USD | €10.00 11.54 USD | €85.70 98.93 USD | €85.85 99.1 USD | €6.84B 7.89B USD | 0 | -€4.61 -5.3 USD | ||
Vaxcyte, Inc.
5VA.MU
DE
|
€45.20 52.18 USD |
0
|
€6.53B 7.53B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €6.53B 7.53B USD | 0 | -€6.06 -6.9 USD | ||
|
Rhythm Pharmaceuticals, Inc.
1RV.F
DE
|
€92.00 106.2 USD |
+8.24
|
€6.31B 7.28B USD | €49.00 56.56 USD | €92.00 106.2 USD | €92.00 106.2 USD | €6.31B 7.28B USD | 0 | -€2.75 -3.1 USD | ||
Vaxcyte, Inc.
5VA.F
DE
|
€43.60 50.33 USD |
+1.87
|
€6.30B 7.27B USD | €6.00 6.93 USD | €43.60 50.33 USD | €43.60 50.33 USD | €6.30B 7.27B USD | 0 | -€6.06 -6.9 USD | ||
|
Merus N.V.
2GH.F
DE
|
€79.00 91.19 USD |
0
|
€6.11B 7.05B USD | €0.00 0 USD | €0.00 0 USD | €0.00 0 USD | €6.11B 7.05B USD | 0 | €0.00 0 USD | ||
Cidara Therapeutics
CDTX
US
|
$221.38 — |
0
|
$6.96B — | $0.00 — | $0.00 — | $0.00 — | $6.96B — | 0 | $0.00 — | ||
|
Merus
MRUS
US
|
$90.00 — |
0
|
$6.83B — | $0.00 — | $0.00 — | $0.00 — | $6.83B — | 0 | $0.00 — | ||
Mirum Pharmaceuticals, Inc.
08D.F
DE
|
€96.04 110.86 USD |
+4.62
|
€5.86B 6.76B USD | €15.00 17.32 USD | €95.70 110.47 USD | €96.04 110.86 USD | €5.86B 6.76B USD | 0 | -€11.91 -13.7 USD | ||
ABIVAX Société Anonyme
AAVXF
US
|
$80.03 — |
-20.96
|
$6.38B — | $500.00 — | $80.03 — | $90.45 — | $6.38B — | 0 | -$5.27 — | ||
Scholar Rock Holding Corporation
2QK.F
DE
|
€44.74 51.64 USD |
+4.97
|
€5.36B 6.19B USD | €30.00 34.63 USD | €44.74 51.64 USD | €44.74 51.64 USD | €5.36B 6.19B USD | 0 | -€3.03 -3.4 USD | ||
Centessa Pharmaceuticals plc
260.F
DE
|
€34.60 39.94 USD |
0
|
€5.35B 6.18B USD | €270.00 311.67 USD | €34.20 39.48 USD | €34.60 39.94 USD | €5.35B 6.18B USD | 0 | -€1.56 -1.8 USD | ||
Legend Biotech Corporation
9LB.F
DE
|
€25.80 29.78 USD |
0
|
€4.99B 5.76B USD | €120.00 138.52 USD | €25.60 29.55 USD | €26.20 30.24 USD | €4.99B 5.76B USD | 0 | -€1.21 -1.3 USD | ||
Ligand Pharmaceuticals Incorporated
LGDN.F
DE
|
€244.00 281.66 USD |
+9.91
|
€4.89B 5.64B USD | €20.00 23.09 USD | €244.00 281.66 USD | €244.00 281.66 USD | €4.89B 5.64B USD | 36.25 | €6.73 7.77 USD | ||
|
CRISPR Therapeutics AG
CRSPN.MX
MX
|
MX$950.00 56.25 USD |
+6.38
|
MX$93.56B 5.54B USD | MX$1.29K 76.5 USD | MX$950.00 56.25 USD | MX$974.10 57.68 USD | MX$93.56B 5.54B USD | 0 | -MX$107.15 -6.3 USD | ||
SK Biopharmaceuticals Co., Ltd.
326030.KS
KR
|
₩90,300 68.16 USD |
+4.27
|
₩7T 5.34B USD | ₩138K 103.86 USD | ₩85,100 64.24 USD | ₩92,400 69.75 USD | ₩7T 5.34B USD | 0 | ₩0 0 USD | ||
|
Xenon Pharmaceuticals Inc.
XP0.F
DE
|
€47.80 55.18 USD |
+0.84
|
€4.62B 5.33B USD | €100.00 115.43 USD | €47.80 55.18 USD | €47.80 55.18 USD | €4.62B 5.33B USD | 0 | -€4.13 -4.7 USD | ||
|
RemeGen Co., Ltd.
REG.F
DE
|
€7.59 8.77 USD |
+6.36
|
€4.57B 5.28B USD | €50.00 57.72 USD | €7.59 8.77 USD | €7.59 8.77 USD | €4.57B 5.28B USD | 44.67 | €0.17 0.2 USD | ||
3SBio Inc.
83B.F
DE
|
€1.80 2.08 USD |
+2.31
|
€4.50B 5.2B USD | €250.00 288.58 USD | €1.80 2.08 USD | €1.80 2.08 USD | €4.50B 5.2B USD | 4.09 | €0.44 0.51 USD | ||
Apellis Pharmaceuticals Inc
1JK.F
DE
|
€34.11 39.37 USD |
0
|
€4.37B 5.04B USD | €10.00 11.54 USD | €34.11 39.37 USD | €34.11 39.37 USD | €4.37B 5.04B USD | 37.48 | €0.91 1.05 USD | ||
|
Asymchem Laboratories (Tianjin) Co., Ltd.
7K90.F
DE
|
€12.00 13.85 USD |
+17.65
|
€4.33B 5B USD | €4.00 4.62 USD | €12.00 13.85 USD | €12.00 13.85 USD | €4.33B 5B USD | 30.00 | €0.40 0.46 USD | ||
|
HLB Co., Ltd.
028300.KQ
KR
|
₩49,650 37.48 USD |
-1.29
|
₩7T 4.98B USD | ₩465K 351.04 USD | ₩49,400 37.29 USD | ₩51,500 38.87 USD | ₩7T 4.98B USD | 0 | ₩0 0 USD | ||
|
Akero Therapeutics
AKRO
US
|
$54.65 — |
0
|
$4.50B — | $0.00 — | $0.00 — | $0.00 — | $4.50B — | 0 | $0.00 — | ||
|
Нет избранных акций
У вас еще нет любимых акций, пожалуйста, добавьте их в избранное, чтобы увидеть их здесь |
|||||||||||